Thus, whereas elevation of intracellular cAMP inhibits DNA-damage induced apoptosis and p53 stabilization in BCP-ALL cells and normal B- and T cells [20], no such effects were seen in myeloma cells. The gene discussed is TP53; the disease is plasma cell myeloma.